JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Slēgts

2.09

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.05

Max

2.12

Galvenie mērījumi
By Trading Economics
Ienākumi	113K -3.5M
Darbinieki	43
EBITDA	-561K -4.1M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+258.85% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 12. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-24M 146M
Iepriekšējā atvēršanas cena	2.09
Iepriekšējā slēgšanas cena	2.09

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 1. maijs 21:36 UTC

Iegādes, apvienošanās, pārņemšana

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

2026. g. 1. maijs 20:40 UTC

Iegādes, apvienošanās, pārņemšana

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

2026. g. 1. maijs 18:37 UTC

Galvenie tirgus virzītāji

Senseonic Shares Slide on Underwritten Offering Price

2026. g. 1. maijs 16:46 UTC

Galvenie tirgus virzītāji

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2026. g. 1. maijs 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 1. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 1. maijs 20:42 UTC

Peļņas

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

2026. g. 1. maijs 19:33 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 1. maijs 19:33 UTC

Tirgus saruna

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

2026. g. 1. maijs 19:18 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

2026. g. 1. maijs 19:13 UTC

Tirgus saruna

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

2026. g. 1. maijs 18:36 UTC

Peļņas

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

2026. g. 1. maijs 18:35 UTC

Peļņas

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

2026. g. 1. maijs 18:28 UTC

Peļņas

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

2026. g. 1. maijs 18:27 UTC

Tirgus saruna

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

2026. g. 1. maijs 18:14 UTC

Iegādes, apvienošanās, pārņemšana

Barclays Completes Acquisition of Best Egg

2026. g. 1. maijs 18:04 UTC

Peļņas

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

2026. g. 1. maijs 17:43 UTC

Tirgus saruna

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

2026. g. 1. maijs 17:37 UTC

Tirgus saruna

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

2026. g. 1. maijs 17:30 UTC

Tirgus saruna

Peļņas

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

2026. g. 1. maijs 17:28 UTC

Tirgus saruna

Peļņas

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

2026. g. 1. maijs 17:21 UTC

Tirgus saruna

Peļņas

Apple Seen Absorbing Higher Memory Costs -- Market Talk

2026. g. 1. maijs 17:19 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

2026. g. 1. maijs 16:38 UTC

Tirgus saruna

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

2026. g. 1. maijs 16:23 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

2026. g. 1. maijs 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 1. maijs 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 1. maijs 16:15 UTC

Peļņas

This AI Stock Is Up 78% This Year. Why It Still Looks Like a Buy. -- Barrons.com

2026. g. 1. maijs 16:11 UTC

Tirgus saruna

Bank of Canada Committed a 'Messaging Blunder' -- Market Talk

2026. g. 1. maijs 16:04 UTC

Peļņas

Exxon Stock Slips. CEO Warns 'Full Impact' of War is Coming. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

258.85% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD 258.85%

Augstākais 12 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.